Please read these terms carefully before using PenPal.
By downloading, installing, or using PenPal, you agree to be bound by these Terms of Service. If you do not agree, do not use the app.
PenPal is a personal health tracking tool for logging GLP-1 medication injections and monitoring weight progress. The app allows you to record injection dates, doses, and sites, track weight measurements, and view insights about your progress.
PenPal is a tracking tool only. It does not provide medical advice, diagnosis, or treatment recommendations. Always consult your healthcare provider before starting, stopping, or changing any medication or treatment plan.
Pharmacokinetic calculations (residual levels, half-life estimates) are based on published clinical data and are approximations only. Residual levels are estimated using first-order elimination kinetics: amount × 0.5^(elapsed hours ÷ half-life hours). Individual responses to medication may vary. Do not use these calculations to make medical decisions.
PenPal does not calculate, recommend, or prescribe medication dosages. The dose options shown in the app are the FDA-approved dose progression for each medication, provided for user reference only. All dosing decisions must be made by your prescribing healthcare provider.
The health data and calculations in PenPal are based on peer-reviewed and regulatory sources. The methodology for each calculation is as follows:
PenPal offers a free tier and optional premium subscriptions:
All your health data is stored locally on your device and optionally in your personal iCloud account. We do not have access to your data and do not share it with any third parties. See our Privacy Policy for full details.
You are responsible for:
PenPal and its content, features, and functionality are owned by the developer and are protected by copyright and other intellectual property laws. Ozempic and Wegovy are registered trademarks of Novo Nordisk A/S. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. PenPal is not affiliated with or endorsed by any pharmaceutical company.
To the fullest extent permitted by law, the developers of PenPal shall not be liable for any indirect, incidental, special, consequential, or punitive damages, or any loss of data, health outcomes, or adverse effects resulting from your use of the app.
PenPal is provided "as is" without warranties of any kind, either express or implied.
You may stop using PenPal at any time by deleting the app. We reserve the right to suspend or terminate access to the service for violations of these terms.
We may update these terms from time to time. Continued use of PenPal after changes constitutes acceptance of the revised terms.
For questions about these terms, contact us at fall4her+penpal@gmail.com
Last updated: February 2026